Turkey: Life Sciences, Biotechnology & Nanotechnology

Turkey's pharmaceutical pricing system undergoes a major restructuring with the publication of the New Pricing Communiqué on August 29, 2026, implementing significant changes including increased Euro/TRY conversion rates, incentive mechanisms for first generic market entry, and the introduction of value-based pricing concepts. The new regulations establish detailed provisions for special product categories while leaving certain implementation details to future secondary legislation.

Life sciences companies in Turkey navigate a complex regulatory framework governing interactions with healthcare professionals, where promotional activities face strict oversight and compliance expectations continue to intensify. While pharmaceutical promotion remains limited to healthcare professionals with mandatory transparency reporting, medical device regulations show signs of convergence in enforcement practices.

The Regulation on Cannabis Cultivation and Control ("Cultivation Regulation") and the Regulation on Products Derived from Cannabis ("Product Regulation") were published in the Official Gazette dated 31 January 2026 and numbered 33154, and have entered into force on the same date.